No photo of Christopher J. Destache

View Scopus Profile

Christopher J. Destache, PharmD, FCCP

Professor

  • 2390 Citations
  • 26 h-Index
1985 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher J. Destache is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Nanoparticles Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Rilpivirine Medicine & Life Sciences
HIV Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2018

Long-acting antiretroviral nanoparticles for HIV prophylaxis

Destache, C. J.

National Institutes of Health

2/4/15 → 1/31/18

Project: Research project

Nanoparticles
HIV
Rilpivirine
Tenofovir
Drug Combinations

Once Monthly Antiretroviral Nanoparticles for HIV-1 Treatment

Destache, C. J.

National Institutes of Health

6/15/11 → 5/31/13

Project: Research project

Nanoparticles
HIV-1
Therapeutics
Macaca
Macaca nemestrina

Pharmacology of Antiretroviral Nanoparticle Micelles

Destache, C. J.

National Institutes of Health

6/1/08 → 5/31/11

Project: Research project

Micelles
Nanoparticles
HIV-1
Pharmacology
efavirenz

Research Output 1985 2019

2 Citations (Scopus)

A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study

Mandal, S., Prathipati, P. K., Belshan, M. & Destache, C. J., Jul 1 2019, In : Antiviral Research. 167, p. 83-88 6 p.

Research output: Contribution to journal › Article

Drug Delivery Systems
HIV Infections
HIV-1
Integrases
Emulsions

A review of CCR5 antibodies against HIV: current and future aspects

Prathipati, P. K., Mandal, S. & Destache, C. J., Feb 1 2019, In : Therapeutic Delivery. 10, 2, p. 107-112 6 p.

Research output: Contribution to journal › Article

HIV Antibodies
HIV
Viruses
Antibodies
Virus Diseases
3 Citations (Scopus)

Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experience

Destache, C. J., Guervil, D. J. & Kaye, K. S., Jan 1 2019, In : International Journal of Antimicrobial Agents.

Research output: Contribution to journal › Article

Open Access
Endocarditis
Therapeutics
Methicillin-Resistant Staphylococcus aureus
Methicillin
PPI-0903

Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model (Pharmaceutical Research, (2017), 34, 12, (2749-2755), 10.1007/s11095-017-2255-7)

Prathipati, P. K., Mandal, S., Pon, G., Vivekanandan, R. & Destache, C. J., Jul 1 2019, In : Pharmaceutical Research. 36, 7, 108.

Research output: Contribution to journal › Comment/debate

Open Access
Pharmacokinetics
Tissue Distribution
Nanoparticles
Tissue
Pharmaceutical Preparations

Corrigendum to “Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission” [Journal of Controlled Release 294 (2019)216–225](S0168365918307302)(10.1016/j.jconrel.2018.12.027)

Mandal, S., Kang, G., Prathipati, P. K., Zhou, Y., Fan, W., Li, Q. & Destache, C. J., Jun 28 2019, In : Journal of Controlled Release. 304, 1 p.

Research output: Contribution to journal › Comment/debate

Drug Combinations
HIV-1
Pharmacokinetics
Drug Interactions
Pharmaceutical Preparations